Logo image of BON.PA

BONDUELLE SCA (BON.PA) Stock Fundamental Analysis

Europe - EPA:BON - FR0000063935 - Common Stock

7.72 EUR
+0.44 (+6.04%)
Last: 9/18/2025, 3:25:41 PM
Fundamental Rating

3

BON gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 58 industry peers in the Food Products industry. BON may be in some trouble as it scores bad on both profitability and health. BON has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year BON has reported negative net income.
BON had a positive operating cash flow in the past year.
Of the past 5 years BON 4 years were profitable.
BON had a positive operating cash flow in 4 of the past 5 years.
BON.PA Yearly Net Income VS EBIT VS OCF VS FCFBON.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

Looking at the Return On Assets, with a value of -6.06%, BON is doing worse than 82.76% of the companies in the same industry.
The Return On Equity of BON (-21.14%) is worse than 82.76% of its industry peers.
BON has a Return On Invested Capital (5.16%) which is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for BON is below the industry average of 7.05%.
The 3 year average ROIC (3.87%) for BON is below the current ROIC(5.16%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -6.06%
ROE -21.14%
ROIC 5.16%
ROA(3y)-1.26%
ROA(5y)0.26%
ROE(3y)-4.23%
ROE(5y)0.55%
ROIC(3y)3.87%
ROIC(5y)4%
BON.PA Yearly ROA, ROE, ROICBON.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

BON has a Operating Margin (3.73%) which is comparable to the rest of the industry.
BON's Operating Margin has declined in the last couple of years.
The Gross Margin of BON (28.41%) is worse than 74.14% of its industry peers.
BON's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 3.73%
PM (TTM) N/A
GM 28.41%
OM growth 3Y7.56%
OM growth 5Y-6.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.27%
GM growth 5Y0.61%
BON.PA Yearly Profit, Operating, Gross MarginsBON.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BON is still creating some value.
Compared to 1 year ago, BON has about the same amount of shares outstanding.
The number of shares outstanding for BON remains at a similar level compared to 5 years ago.
Compared to 1 year ago, BON has a worse debt to assets ratio.
BON.PA Yearly Shares OutstandingBON.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
BON.PA Yearly Total Debt VS Total AssetsBON.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

An Altman-Z score of 1.90 indicates that BON is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 1.90, BON is in line with its industry, outperforming 43.10% of the companies in the same industry.
BON has a Debt/Equity ratio of 0.88. This is a neutral value indicating BON is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.88, BON is doing worse than 68.97% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.88
Debt/FCF N/A
Altman-Z 1.9
ROIC/WACC1.03
WACC5.01%
BON.PA Yearly LT Debt VS Equity VS FCFBON.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

BON has a Current Ratio of 1.33. This is a normal value and indicates that BON is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of BON (1.33) is comparable to the rest of the industry.
A Quick Ratio of 0.43 indicates that BON may have some problems paying its short term obligations.
BON's Quick ratio of 0.43 is on the low side compared to the rest of the industry. BON is outperformed by 81.03% of its industry peers.
Industry RankSector Rank
Current Ratio 1.33
Quick Ratio 0.43
BON.PA Yearly Current Assets VS Current LiabilitesBON.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2

3. Growth

3.1 Past

The earnings per share for BON have decreased strongly by -8526.77% in the last year.
Looking at the last year, BON shows a decrease in Revenue. The Revenue has decreased by -1.04% in the last year.
The Revenue has been decreasing by -3.11% on average over the past years.
EPS 1Y (TTM)-8526.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-215.38%
Revenue 1Y (TTM)-1.04%
Revenue growth 3Y3.11%
Revenue growth 5Y-3.11%
Sales Q2Q%-1.74%

3.2 Future

BON is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.57% yearly.
The Revenue is expected to grow by 2.07% on average over the next years.
EPS Next Y-15.39%
EPS Next 2Y22.13%
EPS Next 3Y21.03%
EPS Next 5Y19.57%
Revenue Next Year-7.88%
Revenue Next 2Y-3.4%
Revenue Next 3Y-1.47%
Revenue Next 5Y2.07%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BON.PA Yearly Revenue VS EstimatesBON.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B 2B 2.5B
BON.PA Yearly EPS VS EstimatesBON.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5 2

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BON. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 5.91 indicates a rather cheap valuation of BON.
Based on the Price/Forward Earnings ratio, BON is valued cheaper than 96.55% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of BON to the average of the S&P500 Index (22.70), we can say BON is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 5.91
BON.PA Price Earnings VS Forward Price EarningsBON.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BON is valued cheaply inside the industry as 96.55% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.08
BON.PA Per share dataBON.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

BON's earnings are expected to grow with 21.03% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.13%
EPS Next 3Y21.03%

2

5. Dividend

5.1 Amount

BON has a Yearly Dividend Yield of 2.68%. Purely for dividend investing, there may be better candidates out there.
BON's Dividend Yield is comparable with the industry average which is at 3.27.
BON's Dividend Yield is comparable with the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 2.68%

5.2 History

The dividend of BON decreases each year by -1.50%.
Dividend Growth(5Y)-1.5%
Div Incr Years0
Div Non Decr Years0
BON.PA Yearly Dividends per shareBON.PA Yearly Dividends per shareYearly Dividends per share 2018 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

The earnings of BON are negative and hence is the payout ratio. BON will probably not be able to sustain this dividend level.
DP-6.39%
EPS Next 2Y22.13%
EPS Next 3Y21.03%
BON.PA Yearly Income VS Free CF VS DividendBON.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M 150M

BONDUELLE SCA

EPA:BON (9/18/2025, 3:25:41 PM)

7.72

+0.44 (+6.04%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)05-06 2025-05-06
Earnings (Next)09-26 2025-09-26/amc
Inst Owners7.04%
Inst Owner ChangeN/A
Ins Owners0.33%
Ins Owner ChangeN/A
Market Cap251.90M
Analysts73.33
Price Target8.93 (15.67%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.68%
Yearly Dividend0.26
Dividend Growth(5Y)-1.5%
DP-6.39%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.05%
PT rev (3m)0.38%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-14.45%
EPS NY rev (3m)-14.45%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.72%
Revenue NY rev (3m)-1.76%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 5.91
P/S 0.11
P/FCF N/A
P/OCF 3.67
P/B 0.41
P/tB 0.78
EV/EBITDA 3.08
EPS(TTM)-4.03
EYN/A
EPS(NY)1.31
Fwd EY16.93%
FCF(TTM)-0.34
FCFYN/A
OCF(TTM)2.11
OCFY27.28%
SpS69.82
BVpS18.75
TBVpS9.87
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.06%
ROE -21.14%
ROCE 7.24%
ROIC 5.16%
ROICexc 5.23%
ROICexgc 6.9%
OM 3.73%
PM (TTM) N/A
GM 28.41%
FCFM N/A
ROA(3y)-1.26%
ROA(5y)0.26%
ROE(3y)-4.23%
ROE(5y)0.55%
ROIC(3y)3.87%
ROIC(5y)4%
ROICexc(3y)4%
ROICexc(5y)4.09%
ROICexgc(3y)5.96%
ROICexgc(5y)6.3%
ROCE(3y)5.42%
ROCE(5y)5.61%
ROICexcg growth 3Y14.41%
ROICexcg growth 5Y-8.74%
ROICexc growth 3Y19.99%
ROICexc growth 5Y-5.6%
OM growth 3Y7.56%
OM growth 5Y-6.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.27%
GM growth 5Y0.61%
F-Score4
Asset Turnover1.07
Health
Industry RankSector Rank
Debt/Equity 0.88
Debt/FCF N/A
Debt/EBITDA 1.76
Cap/Depr 35.89%
Cap/Sales 3.5%
Interest Coverage 250
Cash Conversion 22.37%
Profit Quality N/A
Current Ratio 1.33
Quick Ratio 0.43
Altman-Z 1.9
F-Score4
WACC5.01%
ROIC/WACC1.03
Cap/Depr(3y)55.81%
Cap/Depr(5y)69.55%
Cap/Sales(3y)3.42%
Cap/Sales(5y)3.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8526.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-215.38%
EPS Next Y-15.39%
EPS Next 2Y22.13%
EPS Next 3Y21.03%
EPS Next 5Y19.57%
Revenue 1Y (TTM)-1.04%
Revenue growth 3Y3.11%
Revenue growth 5Y-3.11%
Sales Q2Q%-1.74%
Revenue Next Year-7.88%
Revenue Next 2Y-3.4%
Revenue Next 3Y-1.47%
Revenue Next 5Y2.07%
EBIT growth 1Y33.82%
EBIT growth 3Y10.9%
EBIT growth 5Y-9.45%
EBIT Next Year1309.91%
EBIT Next 3Y146.14%
EBIT Next 5Y75.84%
FCF growth 1Y-71.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y31.64%
OCF growth 3YN/A
OCF growth 5YN/A